Form 4: Aeluma Director Denbaars Acquires 10,121 Shares

Aeluma, Inc. Director Steven Denbaars acquired 10,121 shares of common stock through a restricted stock unit grant.

Summary

• Steven Denbaars, a Director of Aeluma, Inc. (ALMU), acquired 10,121 shares of common stock.
• The transaction occurred on December 3, 2025, and was an acquisition (A) at a price of $0 per share.
• These shares are restricted stock units (RSUs) subject to a vesting schedule.
• Following this transaction, Denbaars beneficially owns 395,209 shares of Aeluma, Inc. common stock.
• The acquisition was made pursuant to a Rule 10b5-1 pre-arranged trading plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting continued insider alignment and incentivization, which is generally favorable for corporate governance and long-term strategy.

Positives

• Director Steven Denbaars received a grant of 10,121 restricted stock units, aligning his interests with long-term shareholder value.
• The grant indicates continued commitment and incentivization of key management personnel.

Risks

• The value of the restricted stock units is tied to the future performance of Aeluma, Inc.'s common stock, exposing the recipient to market fluctuations.
• Future dilution could occur if a significant number of similar equity grants are made to other insiders.

Future Outlook

The vesting schedule for the restricted stock units extends through November 2026, indicating a long-term incentive structure for the director.

Industry Context

StockSavvy.ai notes that equity grants to directors and executives are a standard practice across industries to align management incentives with shareholder interests and promote long-term retention. The use of restricted stock units, vesting over time, is a common mechanism for this purpose.

Comparison to Industry Standards

• The grant of restricted stock units to a director is a common compensation practice, comparable to similar equity incentive programs at technology and growth-oriented companies like NVIDIA or AMD, which frequently use RSUs to attract and retain talent.
• The vesting schedule, extending over approximately one year, is typical for such grants, aiming to incentivize long-term performance and commitment, similar to vesting schedules observed in companies within the semiconductor or specialized electronics sectors.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with long-term company performance, potentially benefiting shareholders through improved governance and strategic focus.
• Employees: While specific to a director, such grants are part of a broader compensation philosophy that can influence employee morale and retention if similar incentive structures are applied across the organization.

Next Steps

• Vesting of approximately 1/12 of the restricted stock units on December 31, 2025.
• Subsequent vesting events for 1/4 of the shares on March 31, June 30, and September 30, 2026.
• Final vesting of 1/6 of the shares on November 30, 2026.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a director, which is a standard compensation practice and indicates continued insider alignment. It does not present new information that would fundamentally alter the investment thesis for Aeluma, Inc., thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Aeluma, ALMU, Steven Denbaars, Form 4, Insider Trading, Restricted Stock Units, RSU, Equity Grant, Director, Beneficial Ownership